Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
1.020
-0.010 (-0.97%)
Jan 28, 2026, 1:25 PM EST - Market open
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $10.98 million as of January 28, 2026. Its market cap has increased by 275.02% in one year.
Market Cap
10.98M
Enterprise Value
382.36K
1-Year Change
275.02%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $42.54T to $10.98M, a decrease of -100.00%. That is a compound annual growth rate of -66.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 11.09M | -1.90% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 12.41M |
| Longeveron | 12.36M |
| Sensei Biotherapeutics | 12.34M |
| Curis | 12.28M |
| NuCana | 12.24M |
| Edesa Biotech | 11.58M |
| GridAI Technologies | 11.30M |
| TransCode Therapeutics | 10.84M |